ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A ceRNA Network Composed of Survival-Related lncRNA miRNAs, and mRNAs in Clear Cell Renal Carcinoma

Lu, Wenjun; Liu, Hengchen; Zhang, Xin; Guo, Yujun; Liu, Lu; Guo, Tieyun; Qu, Liqin; Yang, Shulong*; Li, Zhaozhu*哈尔滨医科大学
Computational and Mathematical Methods in Medicine2022-4-28DOI: 10.1155/2022/8504441
6阅读
引用收藏
分享

摘要

Clear cell renal carcinoma (ccRCC) is one of the most common renal carcinomas worldwide, which has worse prognosis compared with other subtypes of tumors. We propose a potential RNA regulatory mechanism associated with ccRCC progression. Accordingly, we screened out clinical factors and the expression of RNAs and miRNAs of ccRCC from the TCGA database. 9 lncRNAs (FGF12-AS2, WT1-AS, TRIM36-IT1, AC009093.1, LINC00443, TCL6, COL18A1-AS1, AC110619.1, HOTTIP), 2 miRNAs (mir-155 and mir-21), and 3 mRNAs (COL4A4, ERMP1, PRELID2) were selected from differential expression RNAs and built predictive survival models. The survival models performed very well in predicting prognosis and were found to be highly correlated with tumor stage. In addition, the survival-related lncRNA-miRNA-mRNA (ceRNA) network was constructed by 18 RNAs including 12 mRNAs, 2 miRNAs, and 4 lncRNAs. It is found that the "ECM-receptor interaction," "Pathways in cancer," and "Chemokine signaling pathway" as the main pathways in KEGG pathway analysis. Overall, we established predictive survival model and ceRNA network based on multivariate Cox regression analysis. It may open a new approach and potential biomarkers for clinical prognosis and treatment of ccRCC patients.

学科与关键词

关键词
LONG NONCODING RNAS
相关
加载中…
  • The ceRNA Network Has Potential Prognostic Value in Clear Cell Renal Cell Carcinoma: A Study Based on TCGA Database
    Liu, Haosheng; Zhu, Zhaowen; Fang, Jianxiong; Liu, Tianqi; Zhang, Zhenhui; Zhao, Chao; Pu, Xiaoyong*; Liu, Jiumin*Biomed Research International, 2020, 2020: 4830847.被引 4
  • A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma
    Zhang, Zedan; Tang, Yanlin; Liu, Yanjun; Zhuang, Hongkai; Lin, Enyu; Xie, Lu; Feng, Xiaoqiang; Tian, Kaiwen; Zeng, Jiayi; Liu, Jiumin; Yu, Yuming*Journal of Immunology Research, 2021, 2021: 9921466.被引 10
  • Construction and Analysis of lncRNA-miRNAmRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP)
    Yang, Lei; Ma, Tian-Jiao; Zhang, Yu-Bai; Wang, He; An, Rui-Hua*ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2022, 28(6): 42-51.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Computational and Mathematical Methods in Medicine
发表日期
2022-04-28
卷期
第 2022 卷
页码
8504441
DOI
10.1155/2022/8504441
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81871837, 81572117]; Open Project Program of Key Laboratory of Preservation of Human Genetic Resources and Disease Control in China (Harbin Medical University), the Ministry of Education [LPHGRDC2021-007]; Specialized Research Fund for Doctoral Program of Higher Education of China [20132307110007]

作者

  • L

    Lu, Wenjun (第一作者)

    2 · harbin med univ

  • L

    Liu, Hengchen

    2 · harbin med univ

查看全部 9 位作者收起作者
  • Z

    Zhang, Xin

    2 · harbin med univ

  • G

    Guo, Yujun

    2 · harbin med univ

  • L

    Liu, Lu

    2 · harbin med univ

  • G

    Guo, Tieyun

    harbin med univ

  • Q

    Qu, Liqin

    2 · harbin med univ

  • Y

    Yang, Shulong (通讯)

    2 · harbin med univ

  • L

    Li, Zhaozhu (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417